Multiple cross-reactivity to several types of neuromuscular blocking agents in a patient with rocuronium anaphylaxis

Multiple cross-reactivity to several types of neuromuscular blocking agents in a patient with rocuronium anaphylaxis

Bibliographic Details
Main Authors:	Young-Jae Oh, Hyeon-Jeong Lee
Format:	Article
Language:	English
Published:	Korean Society of Anesthesiologists 2013-11-01
Series:	Korean Journal of Anesthesiology
Online Access:	http://ekja.org/upload/pdf/kjae-65-473.pdf

Similar Items

Severe Perioperative Anaphylaxis due to Allergy to the Sugammadex-Rocuronium Complex
by: Alfranca, A., et al.
Published: (2022)

Do bupivacaine, clindamycin, and gentamicin at their clinical concentrations enhance rocuronium-induced neuromuscular block?
by: Soo-Il Lee, et al.
Published: (2013-04-01)

Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey
by: Garduño-Espinosa J, et al.
Published: (2002-05-01)

Rocuronium (ORG-9426) : clinical and pharmacological studies on a new neuromuscular blocking agent
by: Cooper, Andrew Ronald
Published: (1992)

Comparison of residual neuromuscular blockade between two intermediate acting nondepolarizing neuromuscular blocking Agents - Rocuronium and vecuronium
by: Shabana Khan, et al.
Published: (2006-01-01)

Rocuronium-induced anaphylaxis: a case report
by: Kanako Takahashi, et al.
Published: (2019-12-01)

Anaphylaxis with angioedema by rocuronium during induction of general anesthesia -A case report-
by: Won Ju Jeong, et al.
Published: (2010-04-01)

The synergistic effect of gentamicin and clindamycin on rocuronium-induced neuromuscular blockade
by: Ji Hyeon Lee, et al.
Published: (2013-02-01)

Rocuronium-induced neuromuscular block after long pretreatment of clonidine in rabbits
by: Min Seok Koo, et al.
Published: (2010-09-01)

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
by: Chang-Hoon Koo, et al.
Published: (2020-04-01)

Rocuronium bromide induced anaphylaxis in a child -A case report-
by: Young Ho Jang, et al.
Published: (2010-12-01)

Possible mitigation of rocuronium-induced anaphylaxis after administration of sugammadex
by: Cyrus Motamed, et al.
Published: (2012-01-01)

Effects of pretreatment with different neuromuscular blocking agents on facilitation of intubation with rocuronium: A prospective randomized comparative study
by: D S Shashank, et al.
Published: (2014-01-01)

Neuromuscular Characteristics of Rocuronium in Diabetic Patients
by: Ahmet Topal, et al.
Published: (2014-08-01)

Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
by: Akihiro Kashiwai, et al.
Published: (2012-01-01)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
by: Shu Chung Choi, et al.
Published: (2020-08-01)

Skin Testing to Identify Safe Drugs for Patients with Rocuronium-Induced Anaphylaxis
by: Manzo Suzuki, et al.
Published: (2020-01-01)

Effect of ulinastatin on the rocuronium-induced neuromuscular blockade
by: Min Soo Kim, et al.
Published: (2012-03-01)

Reversal with sugammadex for rocuronium-induced deep neuromuscular block after pretreatment of magnesium sulfate in rabbits
by: Woon Seok Kang, et al.
Published: (2017-04-01)

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: an ex vivo laboratory study
by: Ákos I. Fábián, et al.
Published: (2019-05-01)

Characteristics of neuromuscular block after administration of rocuronium bromide in patients with end-stage renal failure
by: Lađević Nebojša, et al.
Published: (2011-01-01)

Analysis of incidence of residue neuromuscular blockade for rocuronium and cisatracurium
by: Qing-Long Dong
Published: (2020-11-01)

Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis
by: Chryssoula Staikou, et al.
Published: (2017-01-01)

The antagonistic effect of neostigmine on rocuronium-, clindamycin-, or both-induced neuromuscular blocking in the rat phrenic nerve-hemidiaphragm
by: Seung Soo Kim, et al.
Published: (2011-10-01)

Phenobarbital influence on neuromuscular block produced by rocuronium in rats Influência do fenobarbital no bloqueio neuromuscular produzido pelo rocurônio em ratos
by: Angélica de Fátima de Assunção Braga, et al.
Published: (2008-08-01)

At therapeutic concentration bupivacaine causes neuromuscular blockade and enhances rocuronium-induced blockade
by: Ji Hyeon Lee, et al.
Published: (2012-05-01)

Refrigerated Stability of Diluted Cisatracurium, Rocuronium, and Vecuronium for Skin Testing after Perioperative Anaphylaxis
by: Dinsmore, Kristen G., et al.
Published: (2018)

The effect of high concentration of magnesium with ropivacaine, gentamicin, rocuronium, and their combination on neuromuscular blockade
by: Won Ji Rhee, et al.
Published: (2015-02-01)

Small doses of epinephrine prolong the recovery from a rocuronium-induced neuromuscular block: a case report
by: Hubert J. Schmitt
Published: (2018-07-01)

Rocuronium bromide : an assessment of its neuromuscular and other effects in clinical anaesthesia
by: McCoy, Eamon Paul
Published: (1995)

Resistance to Neuromuscular Blockade by Rocuronium in Surgical Patients with Spastic Cerebral Palsy
by: Stephanie Lee, et al.
Published: (2021-08-01)

Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or “Innate Hypersensitivity”?
by: David Spoerl, et al.
Published: (2017-06-01)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
by: Tiffany Woo, et al.
Published: (2013-12-01)

Retrospective Study of the Restoration of Neuromuscular Blockage with Sugammadex in Newborns Who Used Rocuronium
by: Hacer Şebnem Türk, et al.
Published: (2019-07-01)

Sugammadex ED90 dose to reverse the rocuronium neuromuscular blockade in obese patients
by: MAURO PRADO DA SILVA, et al.

Effects of dexmedetomidine on the onset and duration of action in non-depolarizing neuromuscular relaxant rocuronium
by: Jiaqi Shan, et al.
Published: (2021-03-01)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
by: Patrick M. Honore, et al.
Published: (2020-05-01)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
by: Michiko Higashi, et al.
Published: (2019-05-01)

Studies on Neuromuscular Blocking and Facilitatory Agents
by: Durant, N. N.
Published: (1978)

Bloqueio neuromuscular residual após o uso de rocurônio ou cisatracúrio Bloqueo neuromuscular residual después del uso de rocuronio o cisatracúrio Residual neuromuscular block after rocuronium or cisatracurium
by: Bruno Salomé de Morais, et al.
Published: (2005-12-01)